# Biotech Daily Digest ‚Äî 2025-11-21

**33 items from 3 sources**

## Summary by Source

- Endpoints News: 5 items
- Fierce Biotech: 5 items
- arXiv q-bio: 23 items


## Endpoints News

- **[GSK, AnaptysBio enter legal battle over decade-old Jemperli licensing deal](https://endpoints.news/gsk-anaptysbio-enter-legal-battle-over-decade-old-jemperli-licensing-deal/)**  
  _Fri, 21 Nov 2025 12:07:36 +0000_  
  GSK subsidiary Tesaro and AnaptysBio are at legal loggerheads over a licensing pact concerning the cancer drug Jemperli that dates back to 2014.

 On Thursday, GSK said Tesaro has filed a ...

- **[Novartis, Moderna detail manufacturing expansions in the US, among others](https://endpoints.news/novartis-moderna-detail-manufacturing-expansions-in-the-us-among-others/)**  
  _Thu, 20 Nov 2025 17:56:16 +0000_  
  Welcome to Endpoints News‚Äô manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more.

 Some pharma companies are starting to add detail to their US manufacturing pledges, after over  ...

- **[Abbott's $21B diagnostic deal; Job cuts at Applied Therapeutics and AbbVie](https://endpoints.news/abbotts-21b-diagnostic-deal-job-cuts-at-applied-therapeutics-and-abbvie/)**  
  _Thu, 20 Nov 2025 16:38:35 +0000_  
  Plus, news about Amgen and AstraZeneca:

 ü§ù Abbott to buy Exact Sciences for $21 billion: The deal announced Thursday is another major life sciences acquisition in a year full of them ...

- **[Dispatches from Jefferies: Why Alkermes wants Avadel, Light Chain‚Äôs hope for CD47, and more](https://endpoints.news/dispatches-from-jefferies-why-alkermes-wants-avadel-light-chains-hope-for-cd47-and-more/)**  
  _Thu, 20 Nov 2025 16:33:02 +0000_  
  LONDON ‚Äì The Jefferies Global Healthcare Conference may have found its groove.

 While last year‚Äôs long queues may be gone, the buzz is still palpable as thousands arrive in London to what ...

- **[AbbVie, Novartis can proceed with legal fight against Utah 340B law](https://endpoints.news/abbvie-novartis-can-proceed-with-legal-fight-against-utah-340b-law/)**  
  _Thu, 20 Nov 2025 15:40:44 +0000_  
  AbbVie and Novartis can continue challenging a Utah law that regulates how drugmakers distribute 340B discounts, a federal court held.

 The ruling is another small win for the pharma industry as it fights across circuits ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/biotech/chutes-ladders-gilead-abruptly-parts-ways-general-counsel" hreflang="en">Chutes &amp; Ladders‚ÄîGilead abruptly parts ways with general counsel</a>](https://www.fiercebiotech.com/biotech/chutes-ladders-gilead-abruptly-parts-ways-general-counsel)**  
  _Nov 20, 2025 4:26pm_  
  Gilead‚Äôs general counsel and EVP of corporate affairs Deborah Telman will hang up the gloves by Dec. 5, the company announced in a brief filing Nov. 15. Gilead didn‚Äôt offer any explanation for Telman‚Äôs departure, plainly stating that the executive‚Äôs employment will ‚Äúterminate later in the month.‚Äù

- **[<a href="https://www.fiercebiotech.com/biotech/nurix-trims-workforce-pivotal-trial-lead-btk-degrader-kicks" hreflang="en">Nurix trims workforce as pivotal trial for lead BTK degrader kicks off</a>](https://www.fiercebiotech.com/biotech/nurix-trims-workforce-pivotal-trial-lead-btk-degrader-kicks)**  
  _Nov 20, 2025 8:42pm_  
  Nurix Therapeutics is trimming its workforce not long after launching a pivotal phase 2 trial for its lead cancer asset.

- **[<a href="https://www.fiercebiotech.com/biotech/contineums-jj-partnered-ms-drug-fails-improve-vision-phase-2" hreflang="en">Contineum's J&amp;J-partnered MS drug fails to improve vision in phase 2</a>](https://www.fiercebiotech.com/biotech/contineums-jj-partnered-ms-drug-fails-improve-vision-phase-2)**  
  _Nov 20, 2025 5:05pm_  
  Contineum Therapeutics‚Äô M1 receptor antagonist has failed to move the needle in a phase 2 vision test for patients with a common form of multiple sclerosis.

- **[<a href="https://www.fiercebiotech.com/biotech/modernas-reshaping-rolls-3-more-pipeline-purges" hreflang="en">Moderna's reshaping rolls on with 3 more pipeline purges</a>](https://www.fiercebiotech.com/biotech/modernas-reshaping-rolls-3-more-pipeline-purges)**  
  _Nov 20, 2025 3:36pm_  
  Moderna, an mRNA specialist known for its COVID-19 vaccine Spikevax, is winding down development of three clinical mRNA programs, including two investigational vaccines for infectious diseases.

- **[<a href="https://www.fiercebiotech.com/biotech/pfizer-details-phase-3-data-mrna-flu-vaccine" hreflang="en">Pfizer's mRNA flu vaccine shows 34.5% greater efficacy than standard shot in phase 3</a>](https://www.fiercebiotech.com/biotech/pfizer-details-phase-3-data-mrna-flu-vaccine)**  
  _Nov 20, 2025 11:02am_  
  Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot securing 34.5% greater effectiveness compared to a control vaccine.


## arXiv q-bio

- **[10 simple rules for data-model integration in theoretical ecology](https://arxiv.org/abs/2511.15721)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2511.15721v1 Announce Type: new 
Abstract: Theoretical ecologists have long leveraged empirical data in various forms to advance ecology. Recently increased volumes and access to ecological data present an expanding set of opportunities for theoreticians to inform model development, framing, and interpretation.‚Ä¶

- **[Prediction of Retention Time in Larger Antisense Oligonucleotide Datasets using Machine Learning](https://arxiv.org/abs/2511.15753)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2511.15753v1 Announce Type: new 
Abstract: Antisense oligonucleotides (ASOs) are nucleic acid molecules with transformative therapeutic potential, especially for diseases that are untreatable by traditional drugs. However, the production and purification of ASOs remain challenging due to the presence of unwanted‚Ä¶

- **[Comparing Bayesian and Frequentist Inference in Biological Models: A Comparative Analysis of Accuracy, Uncertainty, and Identifiability](https://arxiv.org/abs/2511.15839)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2511.15839v1 Announce Type: new 
Abstract: Mathematical models support inference and forecasting in ecology and epidemiology, but results depend on the estimation framework. We compare Bayesian and Frequentist approaches across three biological models using four datasets: Lotka-Volterra predator-prey dynamics (H‚Ä¶

- **[How Mathematical Forms of Chemotherapy and Radiotherapy Bias Model-Optimized Predictions: Implications for Model Selection](https://arxiv.org/abs/2511.15932)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2511.15932v1 Announce Type: new 
Abstract: The move towards personalized treatment and digital twins for cancer therapy requires a complete understanding of the mathematical models upon which these optimized simulation-based strategies are formulated. This study investigates the influence of mathematical model s‚Ä¶

- **[Beat Frequency Induced Transitions in Synchronization Dynamics](https://arxiv.org/abs/2511.15985)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2511.15985v1 Announce Type: new 
Abstract: In neurosciences, the brain processes information via the firing patterns of connected neurons operating across a spectrum of frequencies. To better understand the effects of these frequencies in the neuron dynamics, we have simulated a neuronal network of Izhikevich ne‚Ä¶

- **[Modelling the impact of improving access to healthcare on Hepatitis B prevalence in the Thai-Myanmar border region](https://arxiv.org/abs/2511.16096)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2511.16096v1 Announce Type: new 
Abstract: Introduction: In Thailand, Hepatitis B is still endemic despite a strong program to eliminate the disease. A higher prevalence is reported in the border region and among migrants due to physical, financial and cultural barriers. Policies and programs targeting the borde‚Ä¶

- **[ProtT-Affinity: Sequence-Based Protein-Protein Binding Affinity Prediction Using ProtT5 Embeddings](https://arxiv.org/abs/2511.16113)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2511.16113v1 Announce Type: new 
Abstract: Predicting the binding affinity of protein protein complexes directly from sequence remains a challenging problem, particularly in the absence of reliable structural information. Here I present ProtT Affinity, a sequence only model that combines ProtT5 embeddings with a‚Ä¶

- **[Age-structured model of dengue transmission dynamics with time-varying parameters, and its application to Brazil](https://arxiv.org/abs/2511.16179)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2511.16179v1 Announce Type: new 
Abstract: An age structured mathematical model with time dependent parameters is developed to investigate the dynamics of dengue transmission. Its properties are thoroughly analyzed in the first part of this work, as for example its disease free steady state, the corresponding ef‚Ä¶

- **[Unified all-atom molecule generation with neural fields](https://arxiv.org/abs/2511.15906)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2511.15906v1 Announce Type: cross 
Abstract: Generative models for structure-based drug design are often limited to a specific modality, restricting their broader applicability. To address this challenge, we introduce FuncBind, a framework based on computer vision to generate target-conditioned, all-atom molecul‚Ä¶

- **[Efficient Chromosome Parallelization for Precision Medicine Genomic Workflows](https://arxiv.org/abs/2511.15977)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2511.15977v1 Announce Type: cross 
Abstract: Large-scale genomic workflows used in precision medicine can process datasets spanning tens to hundreds of gigabytes per sample, leading to high memory spikes, intensive disk I/O, and task failures due to out-of-memory errors. Simple static resource allocation methods‚Ä¶

- **[Weakly Supervised Segmentation and Classification of Alpha-Synuclein Aggregates in Brightfield Midbrain Images](https://arxiv.org/abs/2511.16268)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2511.16268v1 Announce Type: cross 
Abstract: Parkinson's disease (PD) is a neurodegenerative disorder associated with the accumulation of misfolded alpha-synuclein aggregates, forming Lewy bodies and neuritic shape used for pathology diagnostics. Automatic analysis of immunohistochemistry histopathological image‚Ä¶

- **[Mesoscale tissue properties and electric fields in brain stimulation - bridging the macroscopic and microscopic scales](https://arxiv.org/abs/2511.16465)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2511.16465v1 Announce Type: cross 
Abstract: Accurate simulations of electric fields (E-fields) in brain stimulation depend on tissue conductivity representations that link macroscopic assumptions with underlying microscopic tissue structure. Mesoscale conductivity variations can produce meaningful changes in E-‚Ä¶

- **[SAM2S: Segment Anything in Surgical Videos via Semantic Long-term Tracking](https://arxiv.org/abs/2511.16618)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2511.16618v1 Announce Type: cross 
Abstract: Surgical video segmentation is crucial for computer-assisted surgery, enabling precise localization and tracking of instruments and tissues. Interactive Video Object Segmentation (iVOS) models such as Segment Anything Model 2 (SAM2) provide prompt-based flexibility be‚Ä¶

- **[Clarifying the conceptual dimensions of representation in neuroscience](https://arxiv.org/abs/2403.14046)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2403.14046v3 Announce Type: replace 
Abstract: Despite the centrality of the notion of representation in neuroscience, the field lacks a unified framework for the concepts used to characterize representation, leading to disparate use of both terminology and measures associated with representation. To offer clari‚Ä¶

- **[Comparative in-silico study of drug release from intraocular implants for glaucoma treatment](https://arxiv.org/abs/2410.01082)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2410.01082v4 Announce Type: replace 
Abstract: Drug-releasing implants are gaining momentum in the treatment of glaucoma. However, they present several limitations, such as the inability to provide an even distribution of the drug in the trabecular meshwork. CFD simulations were used in this work to study the in‚Ä¶

- **[Eigenvector-Based Sensitivity Analysis of Contact Patterns in Epidemic Modeling](https://arxiv.org/abs/2502.20117)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2502.20117v3 Announce Type: replace 
Abstract: Understanding how age-specific social contact patterns and susceptibility influence infectious disease transmission is crucial for accurate epidemic modeling. This study presents an eigenvector-based sensitivity analysis framework to quantify the impact of age-struc‚Ä¶

- **[Brain's Statistical Learning and its Embodied Mechanisms Towards Understanding Creativity and Individuality in Music](https://arxiv.org/abs/2504.10875)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2504.10875v2 Announce Type: replace 
Abstract: Music is a universal feature of human culture, linked to embodied cognitive functions that drive learning, action, and the emergence of creativity and individuality. Evidence highlights the critical role of statistical learning an implicit cognitive process of the b‚Ä¶

- **[A Tripartite Framework for Understanding the Embodied Mind: A Comprehensive Review of Bodily Map Study](https://arxiv.org/abs/2504.14865)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2504.14865v2 Announce Type: replace 
Abstract: People often speak of being "moved beyond words" when witnessing awe-inspiring natural beauty, experiencing profound moral elevation, or encountering powerful works of art and music. Such moments evoke intensely embodied sensations - a swelling in the chest, a quick‚Ä¶

- **[System Filter-Based Common Components Modeling for Cross-Subject EEG Decoding](https://arxiv.org/abs/2507.05268)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2507.05268v2 Announce Type: replace 
Abstract: Brain-computer interface (BCI) technology enables direct communication between the brain and external devices through electroencephalography (EEG) signals. However, existing decoding models often mix common and personalized components, leading to interference from i‚Ä¶

- **[Symbiotic causal network of seagrass-bacteria-algas-diatoms interactions](https://arxiv.org/abs/2511.13799)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13799v3 Announce Type: replace 
Abstract: Seagrass meadows contribute to the conservation of marine ecosystems, reduction in global warming impacts and pathogen controls. However, the decline in seagrass habitats due to environmental loads has become an urgent global issue. One way to address this issue is‚Ä¶

- **[Quantum-machine-assisted Drug Discovery](https://arxiv.org/abs/2408.13479)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2408.13479v5 Announce Type: replace-cross 
Abstract: Drug discovery is lengthy and expensive, with traditional computer-aided design facing limits. This paper examines integrating quantum computing across the drug development cycle to accelerate and enhance workflows and rigorous decision-making. It highlights q‚Ä¶

- **[Measuring and Controlling Solution Degeneracy across Task-Trained Recurrent Neural Networks](https://arxiv.org/abs/2410.03972)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2410.03972v3 Announce Type: replace-cross 
Abstract: Task-trained recurrent neural networks (RNNs) are widely used in neuroscience and machine learning to model dynamical computations. To gain mechanistic insight into how neural systems solve tasks, prior work often reverse-engineers individual trained networks.‚Ä¶

- **[Effect Size-Driven Pathway Meta-Analysis for Gene Expression Data](https://arxiv.org/abs/2501.13583)**  
  _Fri, 21 Nov 2025 00:00:00 -0500_  
  arXiv:2501.13583v2 Announce Type: replace-cross 
Abstract: The proliferation of omics datasets in public repositories has created unprecedented opportunities for biomedical research but has also posed significant challenges for their integration, particularly due to missing genes and platform-specific discrepancies. T‚Ä¶
